91 related articles for article (PubMed ID: 29466210)
1. [Elevated Level of the Natriuretic Peptide Among Adult Population in Regions Participating in the ESSE-RF Study and Its Association With Cardiovascular Diseases and Risk Factors].
Shalnova SA; Imaeva AE; Deev AD; Metelskaya VA; Muromtseva GA; Konradi AO; Masenko VP; Efanov AY; Kulakova NV; Rotar OP; Trubacheva IA; Shabunova AA; SHlyakhto EV; Boytsov SA
Kardiologiia; 2017 Dec; 57(12):43-52. PubMed ID: 29466210
[TBL] [Abstract][Full Text] [Related]
2. Plasma natriuretic peptides and incidence of subtypes of ischemic stroke.
Berntsson J; Zia E; Borné Y; Melander O; Hedblad B; Engström G
Cerebrovasc Dis; 2014; 37(6):444-50. PubMed ID: 25060145
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation.
Roldán V; Vílchez JA; Manzano-Fernández S; Jover E; Gálvez J; Puche CM; Valdés M; Vicente V; Lip GY; Marín F
Stroke; 2014 Mar; 45(3):696-701. PubMed ID: 24519407
[TBL] [Abstract][Full Text] [Related]
4. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
Kistorp C; Raymond I; Pedersen F; Gustafsson F; Faber J; Hildebrandt P
JAMA; 2005 Apr; 293(13):1609-16. PubMed ID: 15811980
[TBL] [Abstract][Full Text] [Related]
5. Long-term pattern of brain natriuretic peptide and N-terminal pro brain natriuretic peptide and its determinants in the general population: contribution of age, gender, and cardiac and extra-cardiac factors.
Luchner A; Behrens G; Stritzke J; Markus M; Stark K; Peters A; Meisinger C; Leitzmann M; Hense HW; Schunkert H; Heid IM
Eur J Heart Fail; 2013 Aug; 15(8):859-67. PubMed ID: 23568644
[TBL] [Abstract][Full Text] [Related]
6. N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation).
Hijazi Z; Wallentin L; Siegbahn A; Andersson U; Christersson C; Ezekowitz J; Gersh BJ; Hanna M; Hohnloser S; Horowitz J; Huber K; Hylek EM; Lopes RD; McMurray JJ; Granger CB
J Am Coll Cardiol; 2013 Jun; 61(22):2274-84. PubMed ID: 23563134
[TBL] [Abstract][Full Text] [Related]
7. Amino-terminal-pro-B-type natriuretic peptide levels and low diastolic blood pressure: potential relevance to the diastolic J-curve.
Campbell DJ; McGrady M; Prior DL; Coller JM; Boffa U; Shiel L; Liew D; Wolfe R; Stewart S; Reid CM; Krum H
J Hypertens; 2014 Nov; 32(11):2158-65; discussion 2165. PubMed ID: 25275245
[TBL] [Abstract][Full Text] [Related]
8. Echocardiographic assessment and N-terminal pro-brain natriuretic peptide in hypertensives with metabolic syndrome.
Krzesiński P; Uziebło-Życzkowska B; Gielerak G; Stańczyk A; Piotrowicz K; Piechota W; Smurzyński P; Skrobowski A
Adv Clin Exp Med; 2017; 26(2):295-301. PubMed ID: 28791849
[TBL] [Abstract][Full Text] [Related]
9. Elevated admission N-terminal pro-brain natriuretic peptide level predicts the development of atrial fibrillation in general surgical intensive care unit patients.
Chokengarmwong N; Yeh DD; Chang Y; Ortiz LA; Kaafarani HMA; Fagenholz P; King DR; DeMoya M; Butler K; Lee J; Velmahos G; Januzzi JL; Lee-Lewandrowski E; Lewandrowski K
J Trauma Acute Care Surg; 2017 Sep; 83(3):485-490. PubMed ID: 28463935
[TBL] [Abstract][Full Text] [Related]
10. Raised plasma aldosterone and natriuretic peptides in atrial fibrillation.
Dixen U; Ravn L; Soeby-Rasmussen C; Paulsen AW; Parner J; Frandsen E; Jensen GB
Cardiology; 2007; 108(1):35-9. PubMed ID: 16968988
[TBL] [Abstract][Full Text] [Related]
11. N-terminal pro-brain natriuretic peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease.
Hess G; Runkel S; Zdunek D; Hitzler WE
Clin Lab; 2005; 51(3-4):167-72. PubMed ID: 15819172
[TBL] [Abstract][Full Text] [Related]
12. [N-terminal pro-brain natriuretic peptide levels and diastolic dysfunction in patients with early rheumatoid arthritis before the administration of disease-modifying antirheumatic drugs].
Kirillova IG; Novikova DS; Popkova TV; Aleksandrova EN; Novikov AA; Gorbunova YN; Markelova EI; Korsakova YO; Glukhova SI; Volkov AV; Luchikhina EL; Demidova NV; Kasumova KA; Vladimirov SA; Kanonirova MA; Lukina GL; Karateev DE; Nasonov EL
Ter Arkh; 2016; 88(5):19-26. PubMed ID: 27239922
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population.
Zhu Q; Xiao W; Bai Y; Ye P; Luo L; Gao P; Wu H; Bai J
Clin Interv Aging; 2016; 11():245-53. PubMed ID: 27013868
[TBL] [Abstract][Full Text] [Related]
14. N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome.
Olsen MH; Hansen TW; Christensen MK; Gustafsson F; Rasmussen S; Wachtell K; Borch-Johnsen K; Ibsen H; Jørgensen T; Hildebrandt P
Hypertension; 2005 Oct; 46(4):660-6. PubMed ID: 16129819
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of multiple emerging biomarkers in cardiovascular risk prediction in patients with stable cardiovascular disease.
Ahluwalia N; Blacher J; Szabo de Edelenyi F; Faure P; Julia C; Hercberg S; Galan P
Atherosclerosis; 2013 Jun; 228(2):478-84. PubMed ID: 23582589
[TBL] [Abstract][Full Text] [Related]
16. N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in a Japanese community: the Hisayama study.
Doi Y; Ninomiya T; Hata J; Hirakawa Y; Mukai N; Ikeda F; Fukuhara M; Iwase M; Kiyohara Y
Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):2997-3003. PubMed ID: 21921261
[TBL] [Abstract][Full Text] [Related]
17. The intracardiac concentrations of the N-terminal-pro B-type natriuretic peptide (NT-proBNP) and the determinants of its secretion in patients with atrial fibrillation.
Streb W; Mitręga K; Szymała M; Woźniak A; Podolecki T; Kalarus Z
Kardiol Pol; 2018; 76(2):433-439. PubMed ID: 29131295
[TBL] [Abstract][Full Text] [Related]
18. Role of NT-proANP and NT-proBNP in patients with atrial fibrillation: Association with atrial fibrillation progression phenotypes.
Büttner P; Schumacher K; Dinov B; Zeynalova S; Sommer P; Bollmann A; Husser D; Hindricks G; Kornej J
Heart Rhythm; 2018 Aug; 15(8):1132-1137. PubMed ID: 29604419
[TBL] [Abstract][Full Text] [Related]
19. [Relationship between the structure-functional state of the heart and brain natriuretic peptide level in patients with arterial hypertension].
Vasiuk IuA; Khadzegova AB; Ivanova SV; Iushchuk EN; Shkol'nik EL; Gabitova RG; Sinitsyna IA; Matveeva OS
Kardiologiia; 2012; 52(6):19-23. PubMed ID: 22839665
[TBL] [Abstract][Full Text] [Related]
20. Amino-terminal B-natriuretic peptide levels and postablation recurrence in hypertensive patients with paroxysmal atrial fibrillation.
Giannopoulos G; Kossyvakis C; Angelidis C; Efremidis M; Panagopoulou V; Letsas K; Bouras G; Vassilikos VP; Goudevenos J; Tousoulis D; Lekakis J; Deftereos S
Heart Rhythm; 2015 Jul; 12(7):1470-5. PubMed ID: 25847478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]